Impax Can't Use 'Unrelated Benefits,' AGs Tell 5th Circ.
Two dozen state attorneys general backed the Federal Trade Commission at the Fifth Circuit in an amicus brief Monday arguing Impax Laboratories shouldn't be able to upend an FTC order finding...To view the full article, register now.
Already a subscriber? Click here to view full article